Announcements Trials
Browse Landscape

Phase

Phase 3 10Phase 2 5Phase 1/2 2Phase 2/3 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 24NIH 6NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Cisplatin 24Radiotherapy 18Carboplatin 18Paclitaxel 17Vincristine 15Cyclophosphamide 14Etoposide 13Filgrastim 12Doxorubicin 12Gemcitabine 11Temozolomide 10Cytarabine 9Topotecan 8Docetaxel 8Methotrexate 7Irinotecan 7Granulocyte Colony-Stimulating Factor 7Dexamethasone 7Taxes 6Radiation 6Peripheral Blood Stem Cell Transplantation 6Radiotherapy, Conformal 5Oxaliplatin 5Melphalan 5Fenretinide 5Chemotherapy, Adjuvant 5Capecitabine 5etoposide phosphate 4Trastuzumab 4Platinum 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × NETWORK × Carmustine × Clear all
NCT00045721 2009-10-16

Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant Glioma

Pediatric Brain Tumor Consortium

Phase 1 Terminated
3 enrolled
CNS

Astrocytoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡